At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
MindCotine's VR appbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation
In Brief
A clinical study evaluating MindCotine's VR app for Smoking Cessation and MindCotine Virtual Reality Mindful Exposure Therapy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
First PostedFeb 2022
Primary CompletionOct 2022
TodayJul 2026
First PostedFeb 2, 2022
Enrollment StartOct 18, 2021
Primary CompletionOct 27, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 4.4 years ago
Interventions
MindCotine's VR appbehavioral
The MindCotine program would be a 6-week intervention to help users utilize mindfulness based skills, and involves virtual exposure therapy.